PHARMA TECH

Regenerative Medicine

September 16, 2022

Regenerative Medicine
T wice a year, we survey the cell and gene therapy landscape and ARM’s initiatives to advance the sector and provide an update to our members. 

Spotlight

Imprimis Pharma Sciences

Imprimis Pharma Sciences, started in the year 2013, is into Process chemistry manufacturing innovative products, Analytical Services and Regulatory services. We at Imprimis understand the customers pulse and reach their expectations. We are unique and focus on quality is our prime goal.

OTHER WHITEPAPERS
news image

Winning with biosimilars Opportunities in global markets

whitePaper | March 14, 2022

Over the past several years, biologics have gained significant traction in the pharmaceutical industry, representing more than $150 billion in global sales in 2013. By 2020 they are predicted to generate $290 billion in revenue and comprise 27 percent of the pharmaceutical market.i

Read More
news image

A Comparison of Substance Use Disorders before and during theCOVID-19 Pandemic

whitePaper | September 22, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

Read More
news image

Pharma R&D Annual Review 2022 Navigating the Landscape

whitePaper | June 27, 2022

Welcome to Pharmaprojects' 2022 reviews of trends in pharmaceutical R&D. Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Read More
news image

Three Challenges Facing Study Start Up and the Low-Code Solution

whitePaper | December 22, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies, the sooner a new treatment can be available for patients.

Read More
news image

Pharma R&D Annual Review 2022

whitePaper | May 5, 2022

welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma

Read More
news image

Asia Pacific – Clinical trial landscape

whitePaper | November 8, 2022

The Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions.

Read More

Spotlight

Imprimis Pharma Sciences

Imprimis Pharma Sciences, started in the year 2013, is into Process chemistry manufacturing innovative products, Analytical Services and Regulatory services. We at Imprimis understand the customers pulse and reach their expectations. We are unique and focus on quality is our prime goal.

Events